Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells.

Daru 2016 Jul 29;24(1):21. Epub 2016 Jul 29.

Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, Iran.

Background: Hyaluronic acid (HA) has been used for target-specific drug delivery because of strong affinity to CD44, a marker in which overexpressed in cancer cells and cancer stem cells. Conjugation of HA to the cytotoxic agents via active targeting can improve efficacy, biodistribution, and water solubility. To be able to benefit from passive targeting as well, a nanoparticulate system by counter ion using a polycation like chitosan may lead to a perfect delivery system.

Methods: Water soluble Hyaluronic acid-Docetaxel (HA-DTX) conjugate was prepared and used to formulate chitosan-coated HA-DTX nanoparticles by polyelectrolyte complex (PEC) method and optimized using Box-Behnken design. Biological evaluation of nanoparticles was done in CD44+ cancer cells.

Results And Discussion: Biological evaluation of optimized formula showed IC50 of nanoparticles for 4 T1 and MCF-7 cell lines were 45.34 μM and 354.25 μM against 233.8 μM and 625.9 μM for DTX, respectively with increased cellular uptake showed by inverted confocal microscope.

Conclusion: Chitosan-coated HA-DTX nanoparticles were more effective against CD44+ cells than free DTX. Chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles fabricated and evaluated in CD44+ cancer cells.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40199-016-0160-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966701PMC
July 2016

Publication Analysis

Top Keywords

cancer cells
12
hyaluronic acid-docetaxel
12
biological evaluation
12
cd44+ cancer
12
coated hyaluronic
8
conjugate nanoparticles
8
ha-dtx nanoparticles
8
nanoparticles cd44+
8
chitosan coated
8
chitosan-coated ha-dtx
8
acid-docetaxel conjugate
8
nanoparticles
6
cancer
5
cells
5
polyelectrolyte complex
4
complex pec
4
nanoparticles polyelectrolyte
4
well nanoparticulate
4
formulate chitosan-coated
4
nanoparticulate system
4

Similar Publications

Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.

Pharm Res 2014 Nov 20;31(11):2988-3005. Epub 2014 May 20.

School of Pharmacy, Shenyang Pharmaceutical University, PO Box No. 122, 103 Wenhua Road, Shenyang, 110016, People's Republic of China.

Purpose: The objective of the work was to evaluate the potential of hyaluronan-based nanoparticles as tumor-targeting nano-systems for CD44-overexpressed cancer therapy.

Methods: The synthesized amphiphilic cholesteryl succinoyl hyaluronan (Chol-Suc-HA) conjugates self-assembled into docetaxel(DTX)-loaded nanoparticles in the aqueous environment. The physiochemical properties of Chol-Suc-HA-DTX NPs were characterized. Read More

View Article and Full-Text PDF
November 2014

Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.

Pharm Res 2014 Apr 24;31(4):1032-45. Epub 2013 Oct 24.

Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, PO Box No. 122, 103 Wenhua Rd., Shenyang, 110016, People's Republic of China.

Purpose: The objective of this work was to develop a multifunctional tumor-targeting nanocarrier based on the mechanism of CD44-mediated endocytosis and pH-induced drug release to improve the therapeutic efficacy of docetaxel (DTX).

Methods: Hyaluronic acid-coated docetaxel-loaded cholesteryl hemisuccinate vesicles (HA-CHEMS vesicles) were prepared. The physiochemical properties and pH-dependent drug release of HA-CHEMS vesicles were evaluated. Read More

View Article and Full-Text PDF
April 2014

Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.

J Nanobiotechnology 2015 Apr 3;13:29. Epub 2015 Apr 3.

Laboratory of Drug Delivery, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy.

Background: Novel polymeric nanoparticles (NPs) specifically designed for delivering chemotherapeutics in the body and aimed at improving treatment activity and selectivity, cover a very relevant area in the field of nanomedicine. Here, we describe how to build a polymer shell of Hyaluronan (HA) and Polyethyleneimine (PEI) on biodegradable NPs of poly(lactic-co-glycolic) acid (PLGA) through electrostatic interactions and to achieve NPs with unique features of sustained delivery of a docetaxel (DTX) drug cargo as well as improved intracellular uptake.

Results: A stable PEI or HA/PEI shell could be obtained by careful selection of layering conditions. Read More

View Article and Full-Text PDF
April 2015

Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.

J Control Release 2017 08 24;259:76-82. Epub 2016 Dec 24.

Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, People's Republic of China. Electronic address:

PLGA nanotherapeutics though representing a most promising platform for targeted cancer therapy are confronted with low stability and insufficient tumor cell uptake. Here, we report that hyaluronic acid (HA) coated PLGA nanoparticulate docetaxel (DTX-HPLGA) is particularly robust and can effectively target and suppress orthotopic human lung cancer. DTX-HPLGA was easily prepared with a small size of 154nm and negative surface charge of -22. Read More

View Article and Full-Text PDF
August 2017